Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John A Donofrio
AddedMar 31, 2024
UpdatedMay 1, 2026
John A Donofrio

John A Donofrio

Board Member, Ampio Pharmaceuticals

John A Donofrio's Career

Ampio Pharmaceuticals
Ampio Pharmaceuticals

Englewood, CO, US

Board Member· Board
Aytu BioPharma
Aytu BioPharma

Englewood, CO, US

Board Member· Board
Epic Health
Epic Health

Miami, FL, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John A Donofrio's Career

Ampio Pharmaceuticals
Ampio Pharmaceuticals
Public$75.9M82008Englewood, CO, US
Board Member· Board

Leadership at Ampio Pharmaceuticals

Michael MartinoMichael MartinoBoard Member
Josh DisbrowJosh DisbrowBoard Member
Mike MacalusoMike MacalusoCo-Founder
J Kevin BuchiJ Kevin BuchiBoard Member
Vivian H LiuVivian H LiuBoard Member
Elizabeth JobesElizabeth JobesBoard Member
Aytu BioPharma
Aytu BioPharma
Public$36M1642015Englewood, CO, US
Board Member· Board

Leadership at Aytu BioPharma

Vivian LiuVivian LiuBoard Member

Similar to Aytu BioPharma

AptinyxAptinyxEvanston, IL, USPharmaceuticalsest. 2015AptinyxEvanston, IL, US · est. 2015

Aptinyx Inc., a US-based bio-pharmaceutical company, specializes in developing novel treatments for brain and nervous system disorders.

Public · $273.9M12
UroGen PharmaUroGen PharmaNew York City, NY, USPharmaceuticalsest. 2004UroGen PharmaNew York City, NY, US · est. 2004

UroGen Pharma Ltd.: A clinical-stage biopharmaceutical firm innovating therapies for uro-oncology.

Public · $422.1M200
Harmony BiosciencesHarmony BiosciencesPlymouth Meeting, PA, USPharmaceuticalsest. 2017Harmony BiosciencesPlymouth Meeting, PA, US · est. 2017

Harmony Biosciences: Innovating therapies for rare neurological disorders in the U.S.

Public · $1.2B200
Arbutus BiopharmaArbutus BiopharmaWarminster, PA, USPharmaceuticalsest. 2017Arbutus BiopharmaWarminster, PA, US · est. 2017

Arbutus Biopharma, a PA-based medical firm, is dedicated to developing a cure for chronic hepatitis B.

Public96
Epic Health
Epic Health
Series A$3M332015Miami, FL, US
CEO· C-Suite · Management

Leadership at Epic Health

Matt WandererMatt WandererFounder

Similar to Epic Health

Precise TelehealthPrecise TelehealthLutherville-Timonium, MD, USChronic Care, Telehealthest. 2016Precise TelehealthLutherville-Timonium, MD, US · est. 2016

Telehealth provider specializing in chronic condition management, offering rewarding careers.

Angel · $600k15
eVisiteVisitMesa, AZ, USTelemedicine Softwareest. 2013eVisitMesa, AZ, US · est. 2013

Evisit, LLC: A telemedicine software provider enabling remote patient care via online video chat.

Series B · $110.8M99
Trellis HealthTrellis HealthSeattle, WA, USHealth Information Softwareest. 2022Trellis HealthSeattle, WA, US · est. 2022

Seattle-based software company, streamlining global health information for families.

Pre-Seed · $120k7
LifeMDLifeMDNew York City, NY, USHealthcare, Telehealthest. 2010LifeMDNew York City, NY, US · est. 2010

Life MD, Inc.: A Florida-based telehealth solution provider, connecting patients and healthcare providers remotely.

Public · $20M220

John A Donofrio's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to John A Donofrio

Steve DentonSteve DentonCEO · EpicAmber SalzmanAmber SalzmanCEO · Epic-BioJohn HahnJohn HahnCo-Founder · EpicRob AbramsRob AbramsCo-Founder & CEO · Epic NeuroDouglas CrawfordDouglas CrawfordFounder · MBC BiolabsMichael MarquardtMichael MarquardtBoard Member · Epi One